Wireless optofluidic systems for programmable in vivo pharmacology and optogenetics

Michael R. Bruchas (Inventor), Jae-Woong Jeong (Inventor), Sang Ii Park (Inventor), Jordan G. McCall (Inventor), Gunchul Shin (Inventor), John A Rogers (Inventor)

Research output: Patent


Provided are implantable, injectable and/or surface mounted biomedical devices and related methods for interfacing with a target tissue. The devices have a substrate, one or more microfluidic channels embedded in or supported by the substrate and a fluid actuator in operational communication with one or more reservoirs and responsive to a wireless control signal. The components of the device are specially configured and packaged to be ultra-thin and mechanically compliant. In some embodiments, the devices are self-powered and fully implantable. The devices can be shaped to provide injection in a minimally invasive manner, thereby avoiding unnecessary tissue damage and providing a platform for long-term implantation for interfacing with biological tissue.
Original languageEnglish (US)
U.S. patent number11160489
Filing date7/1/16
StatePublished - Nov 2 2021


Dive into the research topics of 'Wireless optofluidic systems for programmable in vivo pharmacology and optogenetics'. Together they form a unique fingerprint.

Cite this